The following is an excerpt.
In recent decades there have been many changes and improvements in prenatal genetic screening and diagnosis. The risk, however, of testing with specimens obtained by invasive procedures such as amniocentesis and chorionic villus sampling has led to the search for new methods using mother’s blood specimens obtained noninvasively. The most recent advances in genomics and genomic technologies have resulted in such noninvasive prenatal screenings.
Read the full press release here: ACMG releases statement on noninvasive prenatal screening
